Lipid nanoparticles for delivery of nucleic acids and vaccines
AssigneeAkagera Medicines, Inc.
InventorsDaryl C. Drummond, Ross Fulton, Mark E. Hayes, Dmitri Kirpotin, Alexander Koshkaryev
Life of this patent
Estimating the term…
Loading patent…
AssigneeAkagera Medicines, Inc.
InventorsDaryl C. Drummond, Ross Fulton, Mark E. Hayes, Dmitri Kirpotin, Alexander Koshkaryev
Estimating the term…
Aspects of the present disclosure provides for improved vaccine compositions of ionizable lipid nanoparticles for the delivery of immunogenic nucleic acids to cells. Anionic phospholipids, including phosphatidylserine and phosphatidylglycerol are included in the lipid nanoparticles to increase the transfection efficiency in dendritic cells. In some embodiments, the incorporation of mono-unsaturated alkyl chain analogs in dimethylaminopropyl-dioxolane or heterocyclic ketal ionizable lipids in the formulation provided high levels of transfection in human dendritic cells, compared to other ionizable lipids in the same family, and demonstrated good stability to oxidative damage.
A lipid nanoparticle (LNP) composition comprising a TLR-activating nucleic acid.
A lipid nanoparticle (LNP) composition consisting of:
Dependencies are inferred from the claim text.